Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 Return-on-Tangible-Equity is 11.15% as of Mar. 2026, which is at its 10-year median of 11.15. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,880 Consumer Packaged Goods companies, Sheel Biotech ranks better than 60.8% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Sheel Biotech's annualized net income for the quarter that ended in Mar. 2026 was ₹118 Mil. Sheel Biotech's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹1,054 Mil. Therefore, Sheel Biotech's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 11.15%.
The historical rank and industry rank for Sheel Biotech's Return-on-Tangible-Equity or its related term are showing as below:
NSE:SHEEL'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.55 Med: 11.15 Max: 15.38
Current: 11.15
During the past 5 years, Sheel Biotech's highest Return-on-Tangible-Equity was 15.38%. The lowest was 7.55%. And the median was 11.15%.
NSE:SHEEL's Return-on-Tangible-Equity is ranked better than 60.8% of 1880
companies
in the Consumer Packaged Goods industry
Industry Median: 7.86
vs NSE:SHEEL: 11.15
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Sheel Biotech Return-on-Tangible-Equity Related Terms
Sheel Biotech Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech Return-on-Tangible-Equity Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Return-on-Tangible-Equity
7.55
8.24
15.38
13.74
11.15
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Return-on-Tangible-Equity
7.55
8.24
15.38
13.74
11.15
NSE:SHEEL vs ADM, BG, TSN: Return-on-Tangible-Equity Comparison
For the Farm Products subindustry, Sheel Biotech's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 11.15% mean?
Sheel Biotech (NSE:SHEEL) has a Return-on-Tangible-Equity of 11.15% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sheel Biotech and its competitors. This is near median its historical median of 11.15. Over the past decade, Sheel Biotech's Return-on-Tangible-Equity has ranged from 7.55 to 15.38. According to the industry distribution chart, Sheel Biotech ranks #737 out of 1880 companies in the Consumer Packaged Goods industry, placing it in the top 39.2%.
Is Sheel Biotech's Return-on-Tangible-Equity too high?
Sheel Biotech's current Return-on-Tangible-Equity of 11.15% is near median its 10-year median of 11.15. Over the past 10 years, this metric has ranged from a low of 7.55 to a high of 15.38. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.86. Sheel Biotech's value of 11.15% is 41.9% above this industry median. Based on the distribution chart, Sheel Biotech ranks #737 out of 1880 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Return-on-Tangible-Equity compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #737 out of 1880 companies for Return-on-Tangible-Equity. This puts Sheel Biotech in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.86. Sheel Biotech's value of 11.15% is 41.9% above this benchmark. Historically, Sheel Biotech's own Return-on-Tangible-Equity has ranged from 7.55 to 15.38 over the past decade. While the company's 10-year median is 11.15 vs. the industry median of 7.86, Sheel Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.86, based on 1,880 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current Return-on-Tangible-Equity of 11.15% is 41.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current Return-on-Tangible-Equity is 11.15%, which is near median its own 10-year median of 11.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Return-on-Tangible-Equity of 11.15%. The current Return-on-Tangible-Equity is 11.15%, which is near median its 10-year median of 11.15 and 41.9% above the Consumer Packaged Goods industry median of 7.86. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Return-on-Tangible-Equity is 11.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
